ASTRO 2025: Patient-reported outcome analysis of NRG Oncology trial in limited-stage small cell lung cancer suggests quality of life benefit with twice – (vs once -) daily radiation
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy…
